Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Debt / NOTE 3.000%10/1
-
Market price (% of par)
-
140.22%
-
Total 13F principal
-
$179,672,000
-
Principal change
-
+$152,000
-
Total reported market value
-
$254,147,406
-
Number of holders
-
17
-
Value change
-
+$146,260
-
Number of buys
-
5
-
Number of sells
-
4
Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 as of Q2 2020
As of 30 Jun 2020,
KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 was held by
17 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$179,672,000
in principal (par value) of the bond.
The largest 10 bondholders included
FARALLON CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, STEELHEAD PARTNERS LLC, DeepCurrents Investment Group LLC, Allianz Asset Management GmbH, Davidson Kempner Capital Management LP, LAZARD ASSET MANAGEMENT LLC, Verition Fund Management LLC, Castle Creek Arbitrage, LLC, and CNH PARTNERS LLC.
This page lists
17
institutional bondholders reporting positions
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.